Too many middlemen disconnects you from patients.

See How Close
Lost in Transition Telephones
Lost in Transition

Treating rare disease shouldn’t be like a bad game of telephone, with each step generating chaos and confusion. Patient adherence suffers, quality of care diminishes, manufacturers miss out on vital feedback and cost goes up. But imagine if you could cut past all that. We did.

Learn More

News Details

January 05, 2018

Dohmen joins life science innovators and investors at Biotech Showcase

Dohmen Life Science Services (DLSS) brings its regulatory, compliance and outsourcing expertise to the Biotech Showcase, January, 8-10, in San Francisco.

As a silver sponsor, the DLSS team will showcase integrated services and commercialization models designed to help innovators and investors achieve their business goals.

“Our model provides the bench to bedside services this industry needs,” said Terry Dagnon, Senior Vice President, Denver Operations. “Our clients and those who invest in them, especially value the integration of outsourced services from one provider – a perfect way to maximize budgets, achieve efficiency and reduce risk.”

More than 3,000 biopharmaceutical executives and investors are expected to attend. For more information visit the Biotech Showcase website.